PSA Screening Reduces Prostate Cancer Deaths, Long-Term Data Show



(MedPage Today) — A sustained reduction in deaths from prostate cancer was observed with prostate-specific antigen (PSA) testing in long-term follow-up results from the European Randomized Study of Screening for Prostate Cancer.
After a median…



Source link : https://www.medpagetoday.com/hematologyoncology/prostatecancer/118218

Author :

Publish date : 2025-10-29 21:00:00

Copyright for syndicated content belongs to the linked Source.
Exit mobile version